Stay connected and up-to-date on the latest news and reports. It’s never been easier to know what’s going on in digital health.
.png)
%20(2).png)
It's been another month of great events at HealthXL. Our Boston Global Gathering was a roaring success. We also hosted many virtual roundtables and masterclasses on a number of topics. Additionally, we ran a great webinar on what pharma and MedTech can learn from each other in digital health.
Read more%20(1640x920).png)
HealthXL held its second Global Gathering of the year, in collaboration with Takeda, around the theme of Pharma 3.0: The Next Frontier of Digital Health. The event gathered senior leaders from across the pharmaceutical, MedTech and digital health industries, as well as investors and academics.
Read more%20(1).png)
In this week’s blog, guest author Ahmed Albaiti (Principal, ZS), makes a case for why the recent wave of bad news in digital health may just be the focused push that the industry needs.
Read more%20(2).png)
In the recent years, patient engagement has gained great popularity in healthcare. The most impactful and adoptable solutions come from involving patient experts, key opinion leaders and other key stakeholders in a collaborative 'co-creation' process.
Read more.png)
Our HealthXL meetings in April covered everything from ‘Data Monetisation for MedTech Companies’ to ‘The Potential of OTC DTx Solutions’. To make sure you’re not missing out on the top insights from our communities, and get a sneak peak at some of the conversations, here are my top five takeaways.
Read more.png)
DTx solutions have been developed, theoretically, to remove many of the barriers associated with traditional care models and be more scalable and readily available. However, these solutions are not always accessible or inclusive for the populations that could benefit from them the most.
Read more.png)
Pharma-DTx partnerships can be a good strategy when both the pharma and the DTx companies speak the same language. While successful pilots have been demonstrated, there are challenges in scaling and sustaining innovations that generate value and return on investment (ROI) for pharma companies.
Read more.png)
Our HealthXL meetings in March covered everything from ‘Navigating the DiGA Framework’ to ‘Leveraging Sources of US Government Funding for Digital Health’. Make sure you’re not missing out on the topics that matter the most to our communities and are plugged into the conversation.
Read more.png)
Over the past decade, pharma’s interaction with digital health has grown more sophisticated and purposeful. In the last year however, innovation wrapped around the drug has become the object of budgetary scrutiny in pharmaceutical companies. So why continue to invest in digital health?
Read more
It's been another month of great events at HealthXL, with topics ranging from ‘DTx Reimbursement: Navigating Medicare & Medicaid Coverage’ to ‘Quantifying the Benefits of Digital Biomarkers in Pharma’.
Read more
In recent years, medical affairs has slowly been brought into the digital era with the introduction of tracking tools and new virtual channels for communication with health care practitioners HCPs. Patients' needs and expectations are also changing rapidly.
Read more
With marketing leaders from across leading pharma organisations, Steve Peretz, Healthcare Practice Lead, Digital Products, Appnovation and Angela Rosales, Group Director, Strategy, Appnovation, led the session to share key insights into evolving product approaches with an ecosystem strategy, empower
Read more%20(1).png)
This month, experts from the HealthXL community led meetings on topics ranging from accounting for cultural differences in digital mental health services to reducing financial toxicity in oncology. In this article, Tess gives her top five meeting takeaways from July.
Read more.png)
Digital technology is poised to change healthcare. In this webinar, the panel explored key challenges that lie ahead for this specialty and developments they anticipate to take place over the next 10-15 years as we collectively navigate a path towards a unified, digitally enabled healthcare system.
Read more%20(2).png)
The surging growth in digital health over the last decade may have slowed, but the potential of digital to transform healthcare remains. Digital health companies alongside pharma, MedTech, and other key stakeholders must come together and form strategic partnerships that play to their strengths.
Read more.png)
The path to achieving digital health compliance in software as a medical device (SaMD) and digital health product development can feel like walking a tightrope. With compliance accounting for about 50% of development spend, the task is significant. What can we do about this?
Read more%20(1).png)
As AI reshapes the landscape of healthcare and life sciences, keeping abreast of emerging trends, breakthrough technologies, and innovative applications has become crucial. To help you stay ahead of the curve, we're thrilled to launch our "AI in Healthcare and Life Sciences Community".
Read more